Crocs (NASDAQ:CROX) Exceeds Q4 Expectations, Stock Jumps 17.1%
  • February 13, 2025

Crocs (NASDAQ:CROX) Exceeds Q4 Expectations, Stock Jumps 17.1%

Footwear company Crocs (NASDAQ:CROX) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 3.1% year on year to $989.8 million. On the other hand, next quarter’s revenue guidance of $905.8 million was less impressive, coming in 2.3% below analysts’ estimates. Its non-GAAP profit of $2.52 per share was 11.3% above analysts’ consensus estimates.

Sally Beauty’s (NYSE:SBH) Q4 Earnings Results: Revenue In Line With Expectations, Stock Soars
  • February 13, 2025

Sally Beauty’s (NYSE:SBH) Q4 Earnings Results: Revenue In Line With Expectations, Stock Soars

Beauty supply retailer Sally Beauty (NYSE:SBH) met Wall Street’s revenue expectations in Q4 CY2024, but sales were flat year on year at $937.9 million. On the other hand, next quarter’s revenue guidance of $899.3 million was less impressive, coming in 2.3% below analysts’ estimates. Its non-GAAP profit of $0.43 per share was in line with analysts’ consensus estimates.

West Pharmaceutical Services’s (NYSE:WST) Q4: Beats On Revenue But Stock Drops
  • February 13, 2025

West Pharmaceutical Services’s (NYSE:WST) Q4: Beats On Revenue But Stock Drops

Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 2.3% year on year to $748.8 million. On the other hand, the company’s full-year revenue guidance of $2.89 billion at the midpoint came in 5% below analysts’ estimates. Its non-GAAP profit of $1.82 per share was 5.3% above analysts’ consensus estimates.

Himax (NASDAQ:HIMX) Delivers Strong Q4 Numbers, Stock Jumps 10.5%
  • February 13, 2025

Himax (NASDAQ:HIMX) Delivers Strong Q4 Numbers, Stock Jumps 10.5%

Semiconductor maker Himax Technologies (NASDAQ:HIMX) reported Q4 CY2024 results exceeding the market’s revenue expectations, with sales up 4.2% year on year to $237.2 million. On top of that, next quarter’s revenue guidance ($212.3 million at the midpoint) was surprisingly good and 5.8% above what analysts were expecting. Its GAAP profit of $0.14 per share was 40% above analysts’ consensus estimates.